Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Adriana Weinberg, Stacie L Lambert, Jennifer Canniff, Li Yu, Nancy Lang, Mark T Esser, Judith Falloon & Myron J Levin. (2019) Antibody and B cell responses to an investigational adjuvanted RSV vaccine for older adults. Human Vaccines & Immunotherapeutics 15:10, pages 2466-2474.
Read now
Read now
Articles from other publishers (10)
Alisa Kachikis, Hye Cho & Janet A. Englund. (2023) Respiratory Syncytial Virus—An Update for Prenatal and Primary Health Providers. Obstetrics and Gynecology Clinics of North America.
Crossref
Crossref
Mario Hönemann, Stephanie Thiem, Sandra Bergs, Tom Berthold, Christian Propach, Manuela Siekmeyer, Armin Frille, Tillmann Wallborn, Melanie Maier & Corinna Pietsch. (2023) In-Depth Analysis of the Re-Emergence of Respiratory Syncytial Virus at a Tertiary Care Hospital in Germany in the Summer of 2021 after the Alleviation of Non-Pharmaceutical Interventions Due to the SARS-CoV-2 Pandemic. Viruses 15:4, pages 877.
Crossref
Crossref
Kunyu Zhang, Lei Chen, Chenyu Zhu, Meng Zhang & Chaozhao Liang. (2023) Current Knowledge of Th22 Cell and IL-22 Functions in Infectious Diseases. Pathogens 12:2, pages 176.
Crossref
Crossref
Jen-Min Huang, Shih-Yun Wang, Mei-Ru Lai, Yu-Kai Tseng, Ya-Hui Chi & Li-Min Huang. (2021) Development of a respiratory syncytial virus vaccine using human hepatitis B core-based virus-like particles to induce mucosal immunity. Vaccine 39:24, pages 3259-3269.
Crossref
Crossref
Katherine M. Eichinger, Jessica L. Kosanovich, Madeline Lipp, Kerry M. Empey & Nikolai Petrovsky. (2021) Strategies for active and passive pediatric RSV immunization. Therapeutic Advances in Vaccines and Immunotherapy 9, pages 251513552098151.
Crossref
Crossref
Joaquín Zuñiga, José Alberto Choreño-Parra, Luis Jiménez-Alvarez, Alfredo Cruz-Lagunas, José Eduardo Márquez-García, Gustavo Ramírez-Martínez, Aminadab Goodina, Erika Hernández-Montiel, Luis Alejandro Fernández-López, María Fernanda Cabrera-Cornejo, Carlos Cabello, Manuel Castillejos, Andrés Hernández, Nora E. Regino-Zamarripa, Criselda Mendoza-Milla, Héctor Vivanco-Cid, Alejandro Escobar-Gutierrez, Salvador Fonseca-Coronado, Pablo F. Belaunzarán-Zamudio, Santiago Pérez-Patrigeon, Lourdes Guerrero, Justino Regalado, Gabriel Nájera-Cancino, Sandra Caballero-Sosa, Héctor Rincón-León, Mary Smolskis, Allyson Mateja, Sally Hunsberger, John H. Beigel & Guillermo Ruiz-Palacios. (2020) A unique immune signature of serum cytokine and chemokine dynamics in patients with Zika virus infection from a tropical region in Southern Mexico. International Journal of Infectious Diseases 94, pages 4-11.
Crossref
Crossref
Cameron Griffiths, Steven J. Drews & David J. Marchant. (2017) Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clinical Microbiology Reviews 30:1, pages 277-319.
Crossref
Crossref
Judith Falloon, Fei Ji, Craig Curtis, Stephan Bart, Eric Sheldon, Diane Krieger, Filip Dubovsky, Stacie Lambert, Therese Takas, Tonya Villafana & Mark T. Esser. (2016) A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant. Vaccine 34:25, pages 2847-2854.
Crossref
Crossref
Z. ZHOU, R. GILCA, G. DECEUNINCK, F. D. BOUCHER, H. CHAREST & P. DE WALS. (2015) Predictors of hospitalization for lower respiratory tract infection in children aged <2 years in the province of Quebec, Canada. Epidemiology and Infection 144:5, pages 1035-1044.
Crossref
Crossref
Michael McCarthy, Tonya Villafana, Elizabeth Stillman & Mark T Esser. (2014) Respiratory syncytial virus protein structure, function and implications for subunit vaccine development. Future Virology 9:8, pages 753-767.
Crossref
Crossref